Business ❯ Corporate Strategy ❯ Acquisitions

Market Expansion

Growth Projections Revenue Growth Gaming Companies Pro Customer Offerings Pipeline Development Sales Increase Product Development Financial Technology Global Operations Avidity Biosciences Customer Integration Digital Infrastructure Innovation Growth Forecast Operational Resilience Market Gtreasury Acquisition Strategic Investments Consumer Brands Immunology Sector Growth Prospects Ripple Product Portfolio U.S. Market Northern Ireland Oncology Pipeline Competitive EDGE Growth Opportunities Bradesco Seguros Healthcare Services Cybersecurity Market Stressed Assets

Biogen to Buy RayThera for Up to $1 Billion

The acquisition adds small-molecule anti-inflammatory candidates to Biogen’s pipeline with most payments tied to clinical and regulatory milestones.

Sherwin-Williams Beats Q1 Estimates, Signals Cautious Year With Mid-Single-Digit Q2 Outlook

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Indra Lifts 2026 Targets After Beating 2025, Announces €0.30 Dividend

Knife River Posts Record 2025 Profit, Raises 2026 Outlook on Record Public-Funded Backlog

Novartis Lifts Cancer-Drug Forecasts, Targets 5%–6% Sales Growth Through 2030

Home Depot Cuts Profit Outlook After Q3 Miss as Housing Slump Weighs

Nuburu Seals Binding Deal to Acquire Orbit, Shares Jump on Defense Software Pivot

T-Mobile Closes $4.3 Billion Deal to Acquire UScellular’s Wireless Operations

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline